Kevin Boyle is the founder of Alaunos Therapeutics. is the Chief Executive Officer of Alaunos Therapeutics.
Kevin S. Boyle, Sr. is the Chief Executive Officer of Alaunos Therapeutics, a clinical-stage biotechnology company focused on preclinical and Phase 1/2 trials. He previously served as Executive Vice President of Corporate Development and Investor Relations at Ziopharm Oncology before being appointed to his current role.
Full founder directory · Investor directory · Company funding database · Fundraising library